About the Alliance

Harnessing artificial intelligence to enhance Australian Healthcare.

AI plays a crucial role in improving healthcare, impacting everything from diagnostic interpretation of medical imaging to personalised therapeutics. Creating a smart, adaptive sector that can apply major AI advances is key to sustainable quality healthcare in Australia.

The challenge for the sector is to translate AI advances into real-world health services. This has created a critical research frontier for implementation science in healthcare AI.

The Australian Alliance for Artificial Intelligence in Healthcare brings together more than 90 national and international stakeholder organisations to build a singular national research and translational community that has the capacity to address these challenges and transform healthcare in Australia.

The Alliance has attracted global and local partners capable of developing leading edge research, technologies and resources alongside the industry leaders delivering them and the health services implementing them.

  • Our members cover academia, government, consumer, clinical, and industry organisations.
  • Our expertise spans artificial intelligence, healthcare services, clinical medicine, consumer perspectives, commercialisation, digital health, data science, implementation science, complex project management, governance, regulation and policy.
  • Our health provider partners are engaged across consumer and clinical services in both primary and tertiary care.

Find out more about the people behind the Alliance here.

Alliance Goals

Innovation. Translation. Impact.

The Alliance works to improve health and economic outcomes by supporting the scalable and sustainable development of AI-enabled healthcare in Australia.

We believe that an AI-enabled health service, if developed in a meaningful, careful and collaborative way, will herald new modes of delivery and models of healthcare that are more personalised, effective and safe, and that such action will ensure our healthcare system sustainably remains an international leader.

Our goal is to create a personalised healthcare system; one that can learn from the experiences of past patients and shape the care of future ones.

In particular, the Alliance aims to utilise AI development, research and implementation to:

  • Facilitate translation of AI into clinical services for personalised, safe and effective care
  • Empower the consumer to navigate the healthcare system and be actively involved in their own care
  • Help ensure AI is safe and ethical through development of regulatory and governance frameworks, policy and research
  • Build a health services workforce confident and capable of integrating and delivering AI within the health system.

The Alliance uses four special purpose programs to work towards these goals.

 

Governance

Appropriate management. Transparency. Clear communication.

The AI Alliance governance ensures appropriate management of its strategic programs, robust and transparent financial management, clear governance of IP, safety, and ethics, and clear and appropriate communication across the AI Alliance’s programs and partner organisations. The Governance structure is currently being formed and includes the following Boards, Committees and members.

 

Independent Advisory Board

The Independent Advisory Board will provide oversight of the AI Alliance as an organisation, monitor progress of planned initiatives against defined milestones and budgets, monitor risks, and assist in identifying strategic engagement opportunities.

Professor Michael Kidd AM

Professor Kidd  is the Interim Chair of our Board. Professor Kidd is a past President of the Royal Australian College of General Practitioners as well as the World Organization of Family Doctors. Professor Kidd has chaired multiple boards and brings a deep understanding of governance, health services, and management of large organisations.

Professor Kathryn North AC

Professor North is a key member of the Board. Professor North leads the Murdoch Children’s Research Institute (MCRI), is past Chair of the NHMRC Research Committee, and leads the Australian Genomics Health Alliance. She will provide invaluable guidance informed by her experiences of the Australian Genomics Health Alliance and MCRI.

Scientific International Advisory Committee

The Scientific International Advisory Committee consists of leading international researchers in AI and healthcare who will facilitate global benchmarking of the AI Alliance’s programs and achievements, and identify collaborative opportunities with international research groups, as well as be advocates of the AI Alliance.

Professor Isaac S Kohane

Isaac S Kohane is Chair of the Department of Biomedical Informatics, and leads a doctoral program in genomics and bioinformatics within the Division of Medical Science at Harvard University (USA).

Professor Trisha Greenhalgh OBE

Trisha Greenhalgh OBE is Nuffield Professor of Primary Care Health Sciences and Co-Director of the Interdisciplinary Research In Health Sciences (IRIHS) unit (UK).

Professor Charles Friedman

Charles Friedman is the Josiah Macy Jr. Professor of Medical Education and Chair of the Department of Learning Health Sciences at the University  of Michigan Medical School (USA).

Professor Curtis Langlotz

Curtis Langlotz is Professor of Radiology and Biomedical Informatics, and Director of the Center for Artificial Intelligence in Medicine and Imaging (AIMI Center) at Stanford University (USA).

Dr David Bates

David Bates is Chief of the Division of General Internal Medicine at Brigham and Women’s Hospital, and a Professor of Medicine at Harvard Medical School (USA).

Professor Iain Buchan

Iain Buchan is Chair in Public Health and Clinical Informatics at the University of Liverpool, where he is forming a new Institute of Population Health (UK)

Professor Mark Musen

Mark Musen is Professor of Biomedical Informatics at Stanford University, where he is Director of the Stanford Center for Biomedical Informatics Research (USA).